S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TSHA Taysha Gene Therapies Inc

1.665

-0.095 (-5.40%)

Last Updated: 02:17:18

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 8 January 2025 (6 days ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 4 January 2025 (1 week ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Monday 23 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 7 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 2 November 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 4 October 2024 (3 months ago) • GlobeNewswire Inc.

More Taysha Gene Therapies Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions